hVIVO PLC (LSE:HVO) - Share price - Overview

Stock Report

hVIVO PLC HVO

Last Price
GBX131.00

Day Change
-1.50|-1.13%

As of 24/02/2017
10:43:28 GMT | GBX
Minimum 15 Minutes Delay.

Last Close132.50p
Day Range127.94 - 127.94
Mkt Cap102.30Mil
52-Wk Range127.94 - 239.75
Yield %0.00
ISINGB00B6ZM0X53
Volume782
P/E-5.34
P/S11.70
P/CF-9.56

Share Price

Total Returns 24/02/2017

 Chg (%)  
More ...
hVIVO PLC-35.15 
FTSE 100 TR GBP2.45
 
Financials
201320142015
More ...
Income Statement
Turnover27.4918.477.72
Operating Profit-1.41-23.05-22.00
Net Profit1.51-18.44-17.91
Reported EPS2.90-31.30-26.00
Balance Sheet
Current Assets47.2061.2763.06
Non Current Assets4.758.2121.69
Total Assets51.9569.4884.74
Current Liabilities8.364.6217.50
Total Liabilities9.098.3021.12
Total Equity42.8661.1863.62
Cash Flow
Operating Cash Flow-3.53-19.15-13.60
Net Change in Cash-3.089.52-8.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
09/01/2017PurchaseMr Jaime Ellertson161.0010,11416,284.00
09/01/2017PurchaseMr. Jim Winschel161.002,4843,999.00
17/10/2016PurchaseMr Jaime Ellertson180.108,54615,391.00
17/10/2016PurchaseMr. Jim Winschel180.102,2214,000.00

Company Profile

hVIVO PLC is a life science company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases.

Sector

Biotechnology

Market Position

893 of 1852 Companies

Index

Outlook

(22/09/2016) ceo - "...platform is well-positioned to run at its full potential, positioning hVIVO to advance game-changing therapies with ever-growing speed and agility in 2017 and beyond"

Next Event 20/04/2017

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0014.3016.26
Div Yld (E)0.003.764.07
PEG (E)0.00-0.421.10
ROCE-33.26204.78109.55
Op Mrgn-270.35-11.80-16.88
EPS Grwth0.0040.7731.59
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr Jaime Ellertson
Chief Executive OfficerKym Denny
Chief Financial & Business Officer & CSGraham Yeatman
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.